The OVA-HFD mice receiving anti-TGF-β mAb treatment exhibited attenuated lung fibrosis measured by the hydroxyproline assay and even attenuated goblet cell hyperplasia compared with the untreated OVA-HFD mice (Fig. 6b, c). This evidence concerns the gene TGFB1 and pulmonary fibrosis.